Cargando…

A urine-based methylation signature for risk stratification within low-risk prostate cancer

BACKGROUND: Prostate cancer overdiagnosis and overtreatment represents a major problem. Many men with low-grade disease on biopsy are undergraded and they harbour high-grade disease at prostatectomy with no reliable way to identify these men. We used a novel urine-based 2-gene methylation test to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jatkoe, T A, Karnes, R J, Freedland, S J, Wang, Y, Le, A, Baden, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453961/ https://www.ncbi.nlm.nih.gov/pubmed/25695483 http://dx.doi.org/10.1038/bjc.2015.7

Ejemplares similares

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
por: Klaassen, Zachary, et al.
Publicado: (2014)

Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification
por: Guo, Jinan, et al.
Publicado: (2020)

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
por: Knauer, M, et al.
Publicado: (2010)

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
por: Xylinas, E, et al.
Publicado: (2012)

Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
por: Valeriani, Maurizio, et al.
Publicado: (2014)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
por: Bendifallah, S, et al.
Publicado: (2015)

Codetection of Trichomonas vaginalis and Candida albicans by PCR in Urine Samples in a Low-Risk Population Attended in a Clinic First Level in Central Veracruz, Mexico
por: López-Monteon, A., et al.
Publicado: (2013)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
por: Olivan, M., et al.
Publicado: (2015)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Surveillance of Pediatric Cardiac Surgical Outcome Using Risk Stratifications at a Tertiary Care Center in Thailand
por: Vijarnsorn, Chodchanok, et al.
Publicado: (2011)

Changing presentation of prostate cancer in a UK population – 10 year trends in prostate cancer risk profiles in the East of England
por: Greenberg, D C, et al.
Publicado: (2013)

A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer
por: Ruan, Weimei, et al.
Publicado: (2021)

Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016)

iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers
por: Mao, Xuan-Yu, et al.
Publicado: (2022)

Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer
por: Mellado, B, et al.
Publicado: (2009)

Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems
por: Cano-Palomares, Albert, et al.
Publicado: (2014)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
por: Kluth, L A, et al.
Publicado: (2014)

Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2021)

Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors
por: Griffiths, Robert I., et al.
Publicado: (2014)

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk
por: Melia, J, et al.
Publicado: (2006)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk Stratification
por: Wen, Chenghao, et al.
Publicado: (2022)

Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer
por: Ye, Li-Ping, et al.
Publicado: (2022)

Human Excretion of Bisphenol A: Blood, Urine, and Sweat (BUS) Study
por: Genuis, Stephen J., et al.
Publicado: (2012)

Human Elimination of Phthalate Compounds: Blood, Urine, and Sweat (BUS) Study
por: Genuis, Stephen J., et al.
Publicado: (2012)

Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018)

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
por: Bierhansl, Laura, et al.
Publicado: (2019)

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk
por: Eklund, C M, et al.
Publicado: (2009)

Biomarkers for prostate cancer detection and risk stratification
por: Farha, Mark W., et al.
Publicado: (2022)

Risk stratification for the development of chronic postsurgical pain
por: Schug, Stephan A., et al.
Publicado: (2017)

On Risk Estimation versus Risk Stratification in Early Prostate Cancer
por: Carlsson, Sigrid V., et al.
Publicado: (2016)

Vitamins and Prostate Cancer Risk
por: Donkena, Krishna Vanaja, et al.
Publicado: (2010)

Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management
por: Leapman, Michael S., et al.
Publicado: (2021)

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
por: Gennaro, Kyle H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i83jp992u50ll5ga28tng058i1